Categories AlphaGraphs, Earnings, Health Care

Infographic: A snapshot of Merck’s Q4 2021 earnings

Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than expected earnings and revenues for the fourth quarter. The positive outcome reflects the managements efforts to maintain sustainability through strategic investments in discovery, development and commercialization of medicines and vaccines.

Merck & Co. Q4 2021 earnings infographic

Worldwide sales rose 24% year-over-year to $13.5 billion in the final three months fiscal 2021, which is well above the market’s projection. Excluding foreign exchange impacts, sales grew 23%. The top-line benefitted from strong sales of oncology and human health vaccines.

Net earnings, on an adjusted basis, nearly doubled to $1.80 per share from $0.98 per share in the fourth quarter of 2020, and exceeded the consensus estimates. Unadjusted net income was $3.82 billion or $1.51 per share in the fourth quarter, compared to a loss of $2.62 billion or $1.03 per share in the corresponding period of the previous year.

“We enter 2022 with strong momentum and are moving with speed to bring forward innovations that address critical unmet needs and contribute to global health. This remains at the core of our strategy, and why we are focused on benefitting the patients we serve, and in turn creating long-term value for our shareholders,” said Robert Davis, chief executive officer of Merck.

Read management/analysts’ comments on Merck’s Q4 2021 earnings

Merck’s stock traded lower during Thursday’s premarket session, after closing the previous session higher. It has gained about 7% since the beginning of the year.

Prior Performance

  • Merck Q3 2021 earnings infographic

Most Popular

Snowflake (SNOW) appears to be on solid footing despite cloud slowdown

The cloud computing market witnessed accelerated growth in the last couple of years, as enterprises across the world shifted their digital assets to cloud for ensuring safety and enhancing data

Dollar Tree (DLTR) vs. Dollar General (DG): How did the third quarter turn out for these discount retailers?

In times of high inflation and economic uncertainty, consumers tend to turn to discount retailers in search of more value. The two leading discount retailers Dollar Tree Inc. (NASDAQ: DLTR)

Kroger (KR) looks set to start 2023 with new vigor. Is the stock a buy?

The retail environment has witnessed many changes in customers’ shopping behavior lately, especially after the COVID outbreak. With inflation putting pressure on personal finances, there appears to be a new

Add Comment
Viewing Highlight